Screener
Globus Medical GMED EBITDA
Discontinued — last reported Q2 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Globus Medical’s reported figures.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
FAQ
- What is Globus Medical's EBITDA?
- Globus Medical (GMED) reported EBITDA of $251.93M in Q2 2026.
- How has Globus Medical's EBITDA changed year-over-year?
- Globus Medical's EBITDA increased by 71.7% year-over-year, from $146.74M to $251.93M.
- What is the long-term trend for Globus Medical's EBITDA?
- Over 4 years (2021 to 2025), Globus Medical's EBITDA has grown at a 33.0% compound annual growth rate (CAGR), from $241.82M to $756.66M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Globus Medical's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude